| Document |
Document Title |
|
WO/1993/003419A1 |
A novel blocked photographically useful compound element and process are based on a new blocking group that comprises a beta-ketocarbonyl group that is part of a 5- to 7-member heterocyclic ring containing a hetero-atom not adjacent to t...
|
|
WO/1993/001171A1 |
A heterocyclic cyclohexanedione derivative represented by general formula [I], a salt thereof, a process for producing the same, and a herbicide; wherein R1 represents lower alkyl, cycloalky, phenyl or heterocycle each of which may be su...
|
|
WO/1992/021647A1 |
Compounds of formula (I) wherein R1 and R4 are OH, (CHR5)mCOR6, (CHR5)mCH(OH)R5 or R5; R2 and R3 are H, C1-8alkyl, Het, C3-10cycloalkyl, Het-C1-8alkyl, C2-8alkenyl, Het-C2-8alkenyl, C3-10cycloalkyl-C1-8alkyl or C3-10cycloalkyl-C2-8alkeny...
|
|
WO/1992/020658A1 |
The present invention relates to novel N-substituted azaheterocyclic carboxylic acids and esters thereof of formula (I), a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are ...
|
|
WO/1992/020749A1 |
A water-based recording ink comprising water, pigment, a water-soluble homopolymer, and a copolymer having both hydrophobic and hydrophilic parts. This ink can give printed characters excellent in density, lightfasteness and water resist...
|
|
WO/1992/015553A1 |
A trialkylamine derivative represented by general formula (1) or a pharmacologically acceptable salt thereof, wherein R1 and R2 may be the same or different from each other and each represents lower alkyl; R3, R4 and R5 may be the same o...
|
|
WO/1992/014734A1 |
Compounds of formula (I), wherein X is CH or N; Z is CH=CH or S; A is CH2CH2, CH=CH, CH(OH)CH2, or COCH2; B is a direct link or -CH2-, -CH(CH3)- or -C(CH3)2-, or when Z is CH=CH, B may form a cyclopentane ring fused to the attached benze...
|
|
WO/1992/014725A1 |
Novel compounds of formula (I) where X is S, O; R1-R5 are hydrogen or lower alkyl; R6 is lower alkyl, lower alkenyl, lower cycloalkyl having 1 to 6 carbons, or halogen; A is lower branched chain alkyl having 2 to 6 carbons, cycloalkyl ha...
|
|
WO/1992/014765A1 |
Photopolymerizable compositions which comprise a borate anion, a squarylium sensitizer, comprising: a squarylium compound selected from the group consisting of (a) and (b) and, in the preferred case, a halomethyl triazine are disclosed.
|
|
WO/1992/013848A1 |
Certain novel hydroxamic acid and hydroxyurea derivatives having structure (I), wherein R1 is hydrogen, alkyl, alkenyl, amino or substituted amino, R4 is hydrogen, a pharmaceutically acceptable cation, aroyl or alkoyl, A is alkylene or a...
|
|
WO/1992/013850A1 |
The invention relates to novel gamma-pyrones, gamma-pyridones and gamma-thiopyrones and their use as medicaments against viral diseases, preferably for the treatment of retroviral diseases, comprising compounds of the formula (I), in whi...
|
|
WO/1992/012222A1 |
Alkylated diphenyl ethers, alkylated diphenyl methanes, alkylated phenoxathins and alkylated diphenyl sulfides are high-temperature stable lubricant fluids having excellent low temperature viscometrics, and excellent additive solubility....
|
|
WO/1992/010480A1 |
Substituted 5-aminopyrazols have formula (I), in which R?1¿ stands for C¿1?-C¿8?-alkyl, C¿1?-C¿8?-hydroxyalkyl, phenyl, that can also carry 1-3 of the following residues: halogen, nitro, alkyl, halogen alkyl, alkoxy, halogen alkoxy,...
|
|
WO/1992/007567A1 |
Novel imidazolidinone derivatives are described which inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease stated mediated or exacerbated by TNF production. The compounds of the present invention are...
|
|
WO/1992/006683A1 |
The present invention relates to a method of treating a retrovirus utilizing a compound of the formula (I): (R¿2?)¿n?R¿1?-Ar-X-Y-R(T¿1?)(T¿2?)¿m?. The present invention also relates to pharmaceutical compositions in which the activ...
|
|
WO/1992/006084A1 |
Retinoid-like activity is exhibited by compounds of formula (I), where X is S, O; R1, R2 and R3 are hydrogen or lower alkyl; R4 and R5 are hydrogen or lower alkyl with the proviso that R4 and R5 cannot both be hydrogen, R6 is hydrogen, l...
|
|
WO/1992/004326A1 |
Compounds useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by formula (1.0), and their pharmaceutically acceptable salts and solvates; wherein: (A) X is...
|
|
WO/1992/004328A1 |
Compounds useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by compounds of formula (1.0) and their pharmaceutically acceptable salts and solvates. Pharm...
|
|
WO/1992/004327A1 |
Compounds useful as antihypertensive agents and useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by formula (1.0) and their pharmaceutically acceptable ...
|
|
WO/1992/003131A1 |
A class of heterocyclic amino-alcohol compounds is described for treatment of CNS-related diseases, namely, for use as a neuroprotective agent, to reduce neurotoxic injury associated with conditions of hypoxia, anoxia or ischemia which t...
|
|
WO/1992/000294A1 |
A naphthothiopyranone derivative of general formula (I) or an acid addition salt thereof, wherein R1 represents hydrogen or C1 to C4 alkyl. It has a more excellent serotonin 3 receptor antagonism than that of conventional compounds and v...
|
|
WO/1991/019725A2 |
Heterocyclic anthracyclinone and anthracycline derivatives are described, which are useful in the treatment of cancer and tumors, such as breast cancer, leukemia, lung cancer, colon cancer, ovarian cancer, renal cancer, CNS cancer and me...
|
|
WO/1991/016320A1 |
Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation and their use in the treatment of viral infections, in particular influenza, are described.
|
|
WO/1991/012249A1 |
A chromene derivative of formula (I), wherein each ring of A and B can have one or more substituents; X is an oxygen atom or sulfur atom, Y is an oxygen or sulfur atom or H�2?, Z is a bond, -NH- or a saturated or unsaturated lower alky...
|
|
WO/1991/011448A1 |
Compounds of formula (I) in which X represents oxygen or sulphur; Z represents -CH= or -N= when X represents oxygen; Z represents -CH= when X represents sulphur; R�5? represents hydrogen when R�3? represents methyl, or R�5? represe...
|
|
WO/1991/009853A1 |
Compounds of formula (I), processes for their preparation, pharmaceutical preparations, use of and method of treatment of disorders in CNS by using compounds of formula (I).
|
|
WO/1991/009006A1 |
A compound of formula (I), wherein X is O, CH2, S, SO or SO2; R is F or Cl; R1 is H, C1-C6 alkyl or C2-C6 alkenyl; R2 is H, C1-C6 alkyl or C2-C6 alkenyl; R3 is H, C1-C6 alkyl, a pharmaceutically acceptable salt thereof, an enantiomer the...
|
|
WO/1991/007370A1 |
The present invention relates to a method for the synthesis of alpha, beta-unsaturated ketones which comprises, in the method for the synthesis of alpha, beta-unsaturated ketones represented by general formula (I) (where R1 is an aliphat...
|
|
WO/1991/007368A1 |
The present invention relates to a method for the preparation of alpha,beta-unsaturated ketones represented by general formula (II) (where R is as defined above) which comprises that aldehydes represented by general formula (III): RCHO (...
|
|
WO/1991/007382A1 |
Substituted semicarbazones of formula (I), wherein Q, X, R¿1?, R¿5?, R¿6? and m are as defined in the text; including all geometric and stereoisomers thereof, agricultural compositions containing them and their use as arthropodicides.
|
|
WO/1991/007369A1 |
The present invention relates to a method for the preparation of beta-hydroxyketones represented by general formula (I), (where R is an alkyl group which may have a methyl group at the alpha position, an alkyl group substituted by alkylt...
|
|
WO/1990/012008A1 |
Substituted phenyl, naphthyl, and thienyl N-hydroxy urea compounds form a class of potent inhibitors of 5- and 12-lipoxygenase and are thus useful compounds in the treatment of inflammatory disease states where leukotrienes and other pro...
|
|
WO/1990/011303A1 |
Use of compounds as initiators for cationic polymerization by means of thermal activation or photochemical activation (UV-irradiation) or activation by electron bombardment (EB) is described. The polymerization-initiator consists of a he...
|
|
WO/1990/008763A1 |
The invention concerns novel, pharmaceutically useful, bensheterocyclyl sulphones of formula (I), in which ring A may bear optional halogeno, (1-4C)alkyl or fluoro(1-4C)alkyl substituents; X is oxygen, or a group of the formula -S(O)n- o...
|
|
WO/1990/007495A1 |
Certain substituted semicarbazones, including all geometric and stereoisomers thereof, agricultural compositions containing them and their use as arthropodicides.
|
|
WO/1990/007494A1 |
This invention relates to a new hydroxylamine derivative exhibiting a 5-lipoxygenase inhibitory activity and represented by general formula (I) (wherein R1 stands for aryl, aryloxy, arylthio, aryl(lower)alkyl, or aryl(lower)alkoxy, R2 fo...
|
|
WO/1990/007493A1 |
Novel compounds of formula (I), where X is an aldimino or ketimino group, process for manufacturing them, fungicides containing these compounds as active substances, and the use of these active substances and fungicides to destroy fungi ...
|
|
WO/1990/005132A1 |
The invention relates to substituted allylamine derivatives and nontoxic salts thereof useful as a cholesterol-depressing agent and represented by general formula (I), [wherein A1 and A2 each represents a methine group, N, O or S; Q1 and...
|
|
WO/1990/000053A1 |
Novel HMG-CoA reductase inhibitors are useful as antihypercholesterolemic agents and are represented by structural formulae (I) and (II), wherein A is O, S(O)n or N-R13.
|
|
WO/1989/007456A1 |
The invention relates to a method of preparing a protein or a proteinaceous material labelled with a metal-radionuclide and intended for diagnostic or therapeutic application, by reacting a protein or a proteinaceous material with an age...
|
|
WO/1989/006650A1 |
A dioxetane that includes a fluorescent chromophore spiro-bound at the 4-carbon of the dioxetane. The dioxetane has formula (I), where X is CR7R8, O, S, or N-R (where each R7, R8, and R, independently, is H, alkyl, heteroalkyl, aryl, het...
|
|
WO/1989/006534A1 |
The present invention includes compounds represented by formula (I), wherein X is O or S; R1 and R2 are independently selected from the group consisting of hydrogen, hydroxy, halo, loweralkoxy, thioalkoxy and loweralkyl; or R1 and R2 tak...
|
|
WO/1989/003212A1 |
Variously substituted 3,5-dihydroxy-6,8-nonadienoic acids and esters, are blood cholesterol lowering agents and so are useful in the prevention and treatment of cardiovascular diseases such as atherosclerosis.
|
|
WO/1989/002740A1 |
Compounds of formula (I), wherein R1, R2, A and B are defined hereinbelow. The compounds of the present invention inhibit brain acetylcholinesterase and are useful in the treatment of Alzheimer's disease.
|
|
WO/1989/002739A1 |
Compounds of formula (I) wherein R1, R2, A and B are defined hereinbelow. The compounds of the present invention inhibit brain acetylcholinesterase and are useful in the treatment of Alzheimer's disease.
|
|
WO/1988/006155A1 |
Trifluoromethanesulfonamide derivatives represented by general formula (I), herbicides containing them as effective ingredients, and a process for their preparation. In formula (I), X represents a hydrogen atom, a halogen atom, an alkyl ...
|
|
WO/1988/004652A1 |
Compounds represented by general formula (I) (wherein R1 represents a hydrogen atom, a group of -D-r1 (wherein -D- represents -CO- or -SO2- and r1 represents a lower alkyl group or an optionally substituted phenyl group), an optionally s...
|
|
WO/1987/006133A1 |
Process for killing internal parasites, especially nematodes, trematodes, and cestodes affecting warm blooded animals such as sheep, cattle, swine, goats, dogs, cats, horses and humans as well as poultry by administering an effective amo...
|
|
WO/1987/005014A1 |
Compounds represented by general formula (I), (wherein Y-Z represents (II), -CH=CH- or -CH2CH2-, R1 and R2 each represents a substituent, R3 represents hydrogen, alkyl or alkoxy, R4 represents hydrogen, alkyl, optionally substituted alke...
|
|
WO/1987/004344A1 |
Racemic and chiral (2R, 4R)-4-c-hydroxy-2-r-(substituted)chroman(and thiochroman)-4-acetic acids and their pharmaceutically acceptable salts, their use in the treatment of diabetic complications and intermediates therefor.
|
